Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The aryl hydrocarbon receptor (AHR) is commonly known for its role in the adaptive metabolism of xenobiotics and in the toxic events that follow exposure to 2,3,7,8-tetrachlorodibenzo- p -dioxin (dioxin). Previously, we have demonstrated that the AHR and its heterodimeric partner, the AHR nuclear translocator (ARNT), play a role in the developmental closure of a hepatic vascular shunt known as the ductus venosus (DV). To investigate the mechanism of DV closure, we generated hypomorphic alleles of the Ahr and Arnt loci. Using these models, we then asked whether this vascular defect could be rescued by receptor activation during late development. By manipulating gestational exposure, the patent DV in AHR or ARNT hypomorphs could be efficiently closed by dioxin exposure as early as embryonic day 12.5 and as late as embryonic day 18.5. These findings define the temporal regulation of receptor activation during normal ontogeny and provide evidence to support the idea that receptor activation and AHR–ARNT heterodimerization are essential for normal vascular development. Taken in the broader context, these data demonstrate that similar AHR signaling steps govern all major aspects of AHR biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899
Self-citationMimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.1490345.x · Cited by 626
Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190256997 · Cited by 377
Self-citationIdentification of Functional Domains of the Aryl Hydrocarbon Receptor
Fukunaga, B. N., Probst, M. R., Reisz-Porszasz, S., & Hankinson, O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29270 · Cited by 338
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215
Self-citationIdentification of a Novel Domain in the Aryl Hydrocarbon Receptor Required for DNA Binding
Fukunaga, B. N., & Hankinson, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3743 · Cited by 91
Cited by
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709
Self-citationThe aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
Self-citationAryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries
Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., & Pohjanvirta, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018705 · Cited by 341
Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions
Bock, K. W., & Köhle, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.017 · Cited by 337
RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription
Vogel, C. F. A., Sciullo, E., Li, W., Wong, P., Lazennec, G., & Matsumura, F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0211 · Cited by 319
Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm096 · Cited by 258
Walisser, J. A., Glover, E., Pande, K., Liss, A. L., & Bradfield, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504757102 · Cited by 234
Self-citationKarchner, S. I., Franks, D. G., Kennedy, S. W., & Hahn, M. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509950103 · Cited by 207
Karchner, S. I., Franks, D. G., & Hahn, M. E. (2005) · Biochemical Journal · doi:10.1042/bj20050713 · Cited by 151
Nukaya, M., Moran, S., & Bradfield, C. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809613106 · Cited by 91
Self-citationHarrill, J. A., Hukkanen, R. R., Lawson, M., Martin, G., Gilger, B., Soldatow, V., LeCluyse, E. L., Budinsky, R. A., Rowlands, J. C., & Thomas, R. S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.024 · Cited by 83
Liver Deformation in Ahr-Null Mice: Evidence for Aberrant Hepatic Perfusion In Early Development
Harstad, E. B., Guite, C. A., Thomae, T. L., & Bradfield, C. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020107 · Cited by 67
Self-citationRelevance of the Aryl Hydrocarbon Receptor (AhR) for Clinical Toxicology
Bradshaw, T. D., & Bell, D. R. (2009) · Clinical Toxicology · doi:10.1080/15563650903140423 · Cited by 62
Lin, B. C., Nguyen, L. P., Walisser, J. A., & Bradfield, C. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047068 · Cited by 48
“Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, and Simon MC (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.”
InfluentialSelf-citationMezrich, J. D., Nguyen, L. P., Kennedy, G., Nukaya, M., Fechner, J. H., Zhang, X., Xing, Y., & Bradfield, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044547 · Cited by 40
Self-citationMoffat, I. D., Roblin, S., Harper, P. A., Okey, A. B., & Pohjanvirta, R. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037218 · Cited by 30
“Mice that are hypomorphic for AHR expression are resistant to TCDD toxicity (Walisser et al., 2004).”
BackgroundRodent Genetic Models of Ah Receptor Signaling
Wilson, R. H., & Bradfield, C. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1955916 · Cited by 16
“Mice hypomorphic for AHR exhibit a patent DV with 12% penetrance and a 7-fold lower level of CYP1A1 activity (Walisser et al. 2004).”
BackgroundMethodInfluentialSelf-citationGeneration of an Allelic Series at the Ahr Locus Using an Edited Recombinant Approach
Wilson, R. H., Carney, P. R., Glover, E., Parrott, J. C., Rojas, B. L., Moran, S. M., Yee, J. S., Nukaya, M., Goetz, N. A., Rubinstein, C. D., et al. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab005 · Cited by 15
Self-citation
Metadata
- Authors
- Walisser, J. A., Bunger, M. K., Glover, E., & Bradfield, C. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-11-15
- Volume
- 101
- Issue
- 47
- Pages
- 16677-16682
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2136655543
- Cited by
- 133
- References
- 8
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.